FIELD: genetic engineering, molecular biology, medical-biological industry.
SUBSTANCE: by screening mouse cDNA library the nucleotide sequence encoding protein thrombopoietin is isolated. This protein elicits ability to stimulate MPL-dependent proliferation or differentiation of cell-precursors of myeloid or lymphoid order. Vectors for expression of the prepared encoding sequence in yeast and mammalian cells are constructed. Culturing eucaryotic host-cells transformed with proposed expressing vectors provides preparing significant amount of recombinant thrombopoietin.
EFFECT: improved preparing method.
13 cl, 2 dwg, 5 tbl, 15 ex
Title | Year | Author | Number |
---|---|---|---|
NEW CYTOKINE ZALPHA 11-LIGAND | 2000 |
|
RU2258710C2 |
NEW LIGAND OF CYTOKINE RECEPTOR ZCYTOR17 | 2003 |
|
RU2490276C2 |
THROMBOPOIETIN | 1994 |
|
RU2245365C2 |
DEGRADED ANTIBODY AS TPO AGONIST | 2001 |
|
RU2287534C2 |
METHODS AND PREPARATIONS FOR STIMULATING GROWTH AND DIFFERENTIATION OF MEGACARIOCYTES | 1995 |
|
RU2158603C2 |
MODIFIED ANTAGONISTIC ANTIBODY | 2001 |
|
RU2295537C2 |
HEMOPOIETIC PROTEIN (VARIANTS), DNA SEQUENCE, METHOD FOR PREPARING HEMOPOIETIC PROTEIN, METHOD FOR SELECTIVE EXPANSION OF HEMOPOIETIC CELLS, METHOD FOR PRODUCING DENDRITIC CELLS, METHOD FOR STIMULATING FOR PRODUCING HEMOPOIETIC CELLS IN PATIENT, PHARMACEUTICAL COMPOSITION, METHOD FOR TREATMENT | 1997 |
|
RU2245887C2 |
ISOLATED SOLUBLE IL-20 RECEPTOR (VARIANTS) | 2000 |
|
RU2279441C2 |
HUMAN ANTIBODIES TO IL-β1 | 2001 |
|
RU2286351C2 |
POLYPEPTIDE THROMBOPOIETIN (TPO), DNA ENCODING POLYPEPTIDE TPO (VERSIONS), METHOD OF PREPARING POLYPEPTIDE (VERSIONS), PHARMACEUTICAL COMPOSITION, METHOD OF TREATMENT (VERSIONS), ANTIBODY AGAINST POLYPEPTIDE TPO | 1995 |
|
RU2194074C2 |
Authors
Dates
2004-08-10—Published
1994-08-05—Filed